Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fahima Nekka

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|July 14, 2016
Steady-state volume of distribution of two-compartment models with simultaneous linear and saturated eliminationXiaotian Wu, Fahima Nekka, Jun Li
Journal of Pharmacokinetics and Pharmacodynamics|March 30, 2011
A Bayesian approach for the estimation of patient compliance based on the last sampling informationOlivier Barrière, Jun Li, Fahima Nekka
Journal of Pharmaceutical Sciences|May 30, 2009
Physiologically based predictions of the impact of inhibition of intestinal and hepatic metabolism on human pharmacokinetics of CYP3A substratesFrederique Fenneteau, Patrick Poulin, Fahima Nekka
Bulletin of Mathematical Biology|August 18, 2019
Analytical Solution and Exposure Analysis of a Pharmacokinetic Model with Simultaneous Elimination Pathways and Endogenous Production: The Case of Multiple Dosing AdministrationXiaotian Wu, Fahima Nekka, Jun Li
Chaos (Woodbury, N.Y.)|December 1, 2004
A practical method to experimentally evaluate the Hausdorff dimension: an alternative phase-transition-based methodologyJun Li, Alain Arneodo, Fahima Nekka
Journal of Pharmacokinetics and Pharmacodynamics|October 23, 2009
Assessing drug distribution in tissues expressing P-glycoprotein using physiologically based pharmacokinetic modeling: identification of important model parameters through global sensitivity analysisFrederique Fenneteau, Jun Li, Fahima Nekka
Clinical Pharmacokinetics|February 6, 2020
An Update on Population Pharmacokinetic Analyses of Vancomycin, Part I: In AdultsAbdullah Aljutayli, Amélie Marsot, Fahima Nekka
Chaos (Woodbury, N.Y.)|September 3, 2020
A non-linear deterministic model of action selection in the basal ganglia to simulate motor fluctuations in Parkinson's diseaseMauro Ursino, Florence Véronneau-Veilleux, Fahima Nekka
Pharmaceutics|March 29, 2023
Understanding the Mechanisms and Treatment of Heart Failure: Quantitative Systems Pharmacology Models with a Focus on SGLT2 Inhibitors and Sex-Specific DifferencesJean François Ndiaye, Fahima Nekka, Morgan Craig
Chaos (Woodbury, N.Y.)|July 9, 2021
Introduction to Focus Issue: Dynamical disease: A translational approachJacques Bélair, Fahima Nekka, John G Milton
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Journal of Pharmacokinetics and Pharmacodynamics|July 14, 2016
Steady-state volume of distribution of two-compartment models with simultaneous linear and saturated eliminationXiaotian Wu, Fahima Nekka, Jun Li
Journal of Pharmacokinetics and Pharmacodynamics|March 30, 2011
A Bayesian approach for the estimation of patient compliance based on the last sampling informationOlivier Barrière, Jun Li, Fahima Nekka
Journal of Pharmaceutical Sciences|May 30, 2009
Physiologically based predictions of the impact of inhibition of intestinal and hepatic metabolism on human pharmacokinetics of CYP3A substratesFrederique Fenneteau, Patrick Poulin, Fahima Nekka
Bulletin of Mathematical Biology|August 18, 2019
Analytical Solution and Exposure Analysis of a Pharmacokinetic Model with Simultaneous Elimination Pathways and Endogenous Production: The Case of Multiple Dosing AdministrationXiaotian Wu, Fahima Nekka, Jun Li
Chaos (Woodbury, N.Y.)|December 1, 2004
A practical method to experimentally evaluate the Hausdorff dimension: an alternative phase-transition-based methodologyJun Li, Alain Arneodo, Fahima Nekka
Journal of Pharmacokinetics and Pharmacodynamics|October 23, 2009
Assessing drug distribution in tissues expressing P-glycoprotein using physiologically based pharmacokinetic modeling: identification of important model parameters through global sensitivity analysisFrederique Fenneteau, Jun Li, Fahima Nekka
Clinical Pharmacokinetics|February 6, 2020
An Update on Population Pharmacokinetic Analyses of Vancomycin, Part I: In AdultsAbdullah Aljutayli, Amélie Marsot, Fahima Nekka
Chaos (Woodbury, N.Y.)|September 3, 2020
A non-linear deterministic model of action selection in the basal ganglia to simulate motor fluctuations in Parkinson's diseaseMauro Ursino, Florence Véronneau-Veilleux, Fahima Nekka
Pharmaceutics|March 29, 2023
Understanding the Mechanisms and Treatment of Heart Failure: Quantitative Systems Pharmacology Models with a Focus on SGLT2 Inhibitors and Sex-Specific DifferencesJean François Ndiaye, Fahima Nekka, Morgan Craig
Chaos (Woodbury, N.Y.)|July 9, 2021
Introduction to Focus Issue: Dynamical disease: A translational approachJacques Bélair, Fahima Nekka, John G Milton
Pageof 6